What are the common and differences between ar hcm mvp
Yeah you're right
| Feature | AR (Aortic Regurgitation) | HCM (Hypertrophic Cardiomyopathy) | MVP (Mitral Valve Prolapse) |
|---|---|---|---|
| Structure affected | Aortic valve leaflets / aortic root | Myocardium (ventricular wall/septum) | Mitral valve leaflets + chordae |
| Mechanism | Diastolic backflow from aorta into LV | Asymmetric septal hypertrophy + diastolic dysfunction ± LVOTO | Billowing of mitral leaflets past coaptation point |
| Primary problem | Volume overload of LV | Diastolic dysfunction; ± outflow obstruction | Mechanical valve failure ± mitral regurgitation |
| Genetics | Usually acquired; some connective tissue diseases (Marfan) | Autosomal dominant; >1500 mutations, mainly sarcomeric proteins (β-myosin, MyBP-C, troponin T) | Usually sporadic; connective tissue predisposition |
| Prevalence | 13% men, 8.5% women (mostly trace/mild) | ~1 in 500 general population | ~2-3% general population (most common valve abnormality) |
| AR | HCM | MVP | |
|---|---|---|---|
| LV volume | Dilated (volume overload) | Normal or small (hyperdynamic) | Usually normal |
| LV function | Systolic dysfunction develops late | Diastolic dysfunction (systolic preserved/hyperdynamic) | Usually normal |
| EF | Reduced as disease progresses | Normal or elevated | Normal |
| Cardiac output | Maintained early; falls with decompensation | Normal (reduced effective output due to obstruction) | Normal unless severe MR |
| AR | HCM | MVP | |
|---|---|---|---|
| Type | High-pitched blowing diastolic murmur + systolic flow murmur | Harsh systolic ejection murmur | Midsystolic click + late systolic murmur |
| Best heard | Left sternal border 2nd-3rd ICS (valvular) or upper right sternal border (root disease) | Lower left sternal border / apex | Apex |
| Radiation | Rarely to carotid | Does NOT radiate to carotids | - |
| Intervention | HCM Murmur | MVP (click + murmur) |
|---|---|---|
| Valsalva (strain phase) | Louder (↓ LV filling) | Click moves earlier (toward S1), murmur longer/louder |
| Standing after squatting | Louder (↓ preload) | Click moves earlier, murmur longer |
| Squatting | Softer (↑ LV filling) | Click moves later (toward S2), murmur shorter |
| Passive leg elevation | Softer (↑ preload) | Click moves later, murmur shorter |
| Handgrip | Softer (↑ afterload/LV size) | Click moves earlier, murmur longer |
The key rule: Anything that decreases LV volume → worsens HCM murmur AND moves MVP click earlier. The difference is handgrip - it DECREASES HCM murmur but INCREASES MVP murmur (because increased afterload prevents valve from closing normally).
| AR | HCM | MVP | |
|---|---|---|---|
| LVH | Yes (voltage criteria) | Yes (prominent, with septal Q waves) | Usually normal |
| Q waves | None typically | Septal Q waves (V4-V6, leads I/aVL) - can mimic MI ("pseudoinfarction") | Nonspecific ST/T changes in inferior leads (II, III, aVF) |
| T-wave changes | ST depression / LVH pattern | Upright T waves in leads with Q waves (distinguishes from true MI) | Inferior T-wave inversions common |
| AR | HCM | MVP | |
|---|---|---|---|
| Sudden cardiac death | Rare (only in severe acute AR) | Yes - major risk; #1 cause of SCD in athletes <35 yrs | Rare (only with thickened leaflets) |
| Heart failure | Common in advanced disease | Develops with severe disease; AF triggers acute decompensation | Only if severe MR develops |
| Stroke/thromboembolism | Yes (LA dilation with AF) | Yes (especially with AF) | Yes (~10% with thickened leaflets) |
| Endocarditis | Yes | Yes (mitral valve involvement) | Yes (~10% with thickened leaflets) |
| AR | HCM | MVP | |
|---|---|---|---|
| Medical | Vasodilators (nifedipine, ACE inhibitors) for chronic severe AR; treat underlying cause | Beta-blockers, verapamil, diltiazem (↓ heart rate, improve diastolic filling); disopyramide + beta-blocker for AF | Beta-blockers for palpitations/autonomic symptoms |
| Avoid | - | Nitrates, diuretics (↓ preload worsens obstruction); inotropes; vasodilators | - |
| Surgical/procedural | Aortic valve replacement (AVR or TAVR in high-risk pts) when LVEF <50% or LV dimension >4.5 cm even if asymptomatic | Septal myectomy or alcohol septal ablation for refractory LVOTO | Mitral valve repair/replacement only if severe MR or flail leaflet |
| ICD | Not indicated | ICD for high SCD risk (family history of SCD, recurrent syncope, NSVT) | Very rarely needed |
| Prognosis without surgery | Life expectancy ~2 years once HF develops | Annual mortality <1% overall; worse with high-risk features | Mostly benign; 10% with thickened leaflets have serious events |